[1]
Vallat JM,Sommer C,Magy L, Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. The Lancet. Neurology. 2010 Apr; [PubMed PMID: 20298964]
[2]
Reynolds J,Sachs G,Stavros K, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. Rhode Island medical journal (2013). 2016 Dec 1; [PubMed PMID: 27902997]
[4]
Broers MC,Bunschoten C,Nieboer D,Lingsma HF,Jacobs BC, Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2019; [PubMed PMID: 30669140]
[5]
Kieseier BC,Mathey EK,Sommer C,Hartung HP, Immune-mediated neuropathies. Nature reviews. Disease primers. 2018 Oct 11; [PubMed PMID: 30310069]
[6]
Kiefer R,Kieseier BC,Stoll G,Hartung HP, The role of macrophages in immune-mediated damage to the peripheral nervous system. Progress in neurobiology. 2001 Jun; [PubMed PMID: 11240209]
[7]
Dimachkie MM,Barohn RJ, Chronic inflammatory demyelinating polyneuropathy. Current treatment options in neurology. 2013 Jun; [PubMed PMID: 23564314]
[8]
Latov N, Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nature reviews. Neurology. 2014 Aug; [PubMed PMID: 24980070]
[9]
McCombe PA,Pollard JD,McLeod JG, Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain : a journal of neurology. 1987 Dec; [PubMed PMID: 3427403]
[10]
Jha S,Ansari M,Sonkar K,Paliwal V, Unusual features in chronic inflammatory demyelinating polyneuropathy: Good outcome after prolonged ventilatory support. Journal of neurosciences in rural practice. 2011 Jul; [PubMed PMID: 21897683]
[11]
Mathey EK,Park SB,Hughes RA,Pollard JD,Armati PJ,Barnett MH,Taylor BV,Dyck PJ,Kiernan MC,Lin CS, Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. Journal of neurology, neurosurgery, and psychiatry. 2015 Sep; [PubMed PMID: 25677463]
[13]
Van den Bergh PY,Hadden RD,Bouche P,Cornblath DR,Hahn A,Illa I,Koski CL,Léger JM,Nobile-Orazio E,Pollard J,Sommer C,van Doorn PA,van Schaik IN, European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. European journal of neurology. 2010 Mar; [PubMed PMID: 20456730]
[14]
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. Journal of the peripheral nervous system : JPNS. 2010 Mar; [PubMed PMID: 20433600]
[15]
Gorson KC, An update on the management of chronic inflammatory demyelinating polyneuropathy. Therapeutic advances in neurological disorders. 2012 Nov; [PubMed PMID: 23139706]
[16]
Katz JS,Saperstein DS,Gronseth G,Amato AA,Barohn RJ, Distal acquired demyelinating symmetric neuropathy. Neurology. 2000 Feb 8; [PubMed PMID: 10680792]
[17]
Rajabally YA,Chavada G, Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features. Muscle [PubMed PMID: 19145651]
[18]
Kimura A,Sakurai T,Koumura A,Yamada M,Hayashi Y,Tanaka Y,Hozumi I,Yoshino H,Yuasa T,Inuzuka T, Motor-dominant chronic inflammatory demyelinating polyneuropathy. Journal of neurology. 2010 Apr; [PubMed PMID: 20361294]
[19]
Rajabally YA,Wong SL, Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology. Journal of clinical neuromuscular disease. 2012 Mar; [PubMed PMID: 22538310]
[21]
Sinnreich M,Klein CJ,Daube JR,Engelstad J,Spinner RJ,Dyck PJ, Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology. 2004 Nov 9; [PubMed PMID: 15534252]
[22]
Di Pasquale A,Morino S,Loreti S,Bucci E,Vanacore N,Antonini G, Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Neurology. 2015 Feb 24; [PubMed PMID: 25632087]
[23]
Katzberg HD,Latov N,Walker FO, Measuring disease activity and clinical response during maintenance therapy in CIDP: from ICE trial outcome measures to future clinical biomarkers. Neurodegenerative disease management. 2017 Apr; [PubMed PMID: 28112008]
[24]
Dyck PJ,Litchy WJ,Kratz KM,Suarez GA,Low PA,Pineda AA,Windebank AJ,Karnes JL,O'Brien PC, A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of neurology. 1994 Dec; [PubMed PMID: 7998769]
[25]
Oaklander AL,Lunn MP,Hughes RA,van Schaik IN,Frost C,Chalk CH, Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. The Cochrane database of systematic reviews. 2017 Jan 13; [PubMed PMID: 28084646]
[26]
van Lieverloo GGA,Peric S,Doneddu PE,Gallia F,Nikolic A,Wieske L,Verhamme C,van Schaik IN,Nobile-Orazio E,Basta I,Eftimov F, Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. Journal of neurology. 2018 Sep [PubMed PMID: 29968199]
[28]
Hughes RA,Donofrio P,Bril V,Dalakas MC,Deng C,Hanna K,Hartung HP,Latov N,Merkies IS,van Doorn PA, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. The Lancet. Neurology. 2008 Feb; [PubMed PMID: 18178525]
[29]
Eftimov F,Vermeulen M,van Doorn PA,Brusse E,van Schaik IN, Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012 Apr 3; [PubMed PMID: 22442436]
[30]
Markvardsen LH,Harbo T, Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs. Journal of the neurological sciences. 2017 Jul 15; [PubMed PMID: 28566163]
[31]
van Schaik IN,Bril V,van Geloven N,Hartung HP,Lewis RA,Sobue G,Lawo JP,Praus M,Mielke O,Durn BL,Cornblath DR,Merkies ISJ, Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Neurology. 2018 Jan; [PubMed PMID: 29122523]
[33]
The role of the state laboratory in tuberculosis control., Dowda H Jr,Disalvo AF,, Journal of the South Carolina Medical Association (1975), 1977 Jun [PubMed PMID: 22972066]
[34]
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. The Lancet. Neurology. 2009 Feb; [PubMed PMID: 19136303]
[35]
Hadden RD,Sharrack B,Bensa S,Soudain SE,Hughes RA, Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1999 Jul 13; [PubMed PMID: 10408537]
[36]
Kuntzer T,Radziwill AJ,Lettry-Trouillat R,Naegeli C,Ochsner F,Erne B,Steck AJ,Bogousslavsky J, Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy. Neurology. 1999 Oct 12; [PubMed PMID: 10522905]
[37]
Mygland A,Monstad P,Vedeler C, Onset and course of chronic inflammatory demyelinating polyneuropathy. Muscle [PubMed PMID: 15742374]
[38]
Dyck PJB,Tracy JA, History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Mayo Clinic proceedings. 2018 Jun; [PubMed PMID: 29866282]
[39]
Dyck PJ,Taylor BV,Davies JL,Mauermann ML,Litchy WJ,Klein CJ,Dyck PJ, Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. Muscle [PubMed PMID: 25976871]
[40]
Min DI,Monaco AP, Complications associated with immunosuppressive therapy and their management. Pharmacotherapy. 1991; [PubMed PMID: 1745617]